Home

Shaping the future of psychedelic science and practice in the Asia-Pacific

Join us for three days of keynotes, symposia, networking, and social events spanning research, clinical practice, policy, and ethics. Optional pre-conference workshops. Learn from and connect with leading researchers, clinicians, policymakers, and practitioners from across the region and around the world.

Convened by Monash University's Clinical Psychedelic Lab (Department of Psychiatry) and the Monash psychedelic research community.

Register Submit an abstract Subscribe for updates


Abstract submissions close 18 September 2026.
Early-bird pricing until 18 December 2026.

Speakers

See the full speaker list as it is updated here.

Rick Doblin PhD

Multidisciplinary Association for Psychedelic Studies (MAPS)
Boston, USA

Vidita Vaidya PhD

Tata Institute of Fundamental Research (TIFR)
Mumbai, India

Gül Dölen MD, PhD

University of California Berkeley
San Francisco, USA

Stephen Ross MD

Center for Psychedelic Medicine, New York University (NYU)
New York, USA

Jem Stone

Indigenous Psychedelic-Assisted Therapies (IPAT)
Nimbin, Australia

Tehseen Noorani PhD

University of Auckland
Auckland, New Zealand

Jennifer Mitchell PhD

University of California, San Francisco (UCSF)
San Francisco, USA

Bill Richards STM, PhD

Independent consultant
Baltimore, USA

What to expect

  • Keynotes

    International and regional leaders sharing new research, clinical insights, and perspectives on the future of the field.

  • Symposia, Talks and Posters

    Presentations spanning basic and clinical science, therapeutic practice, implementation, ethics, policy, regulation, culture, philosophy, and the humanities.

  • Pre-conference Workshops

    Optional full- and half-day professional development for clinicians, researchers, and sector leaders.

  • Social & Networking

    A welcoming space to meet others working across psychedelic science and practice, with dedicated opportunities to connect and collaborate.

-

-

-

CAPS27 is committed to fostering a welcoming, respectful, and inclusive environment where everyone feels valued and able to participate. We welcome diverse perspectives, backgrounds, disciplines, and lived experiences, recognising that collaboration across these strengthens psychedelic science and its translation into practice.